Area of research
Surgery · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Radiomics and Machine Learning in Medical Imaging, Epigenetics and DNA Methylation, and Urinary and Genital Oncology Studies.
Spatial Expression of HER2, NECTIN4, and TROP-2 in Muscle-Invasive Bladder Cancer and Metastases: Implications for Pathological and Clinical Management
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer
Assessment of p53 in Endometrial Carcinoma Biopsy and Corresponding Hysterectomy Cases in a Real-World Setting: Which Cases Need Molecular Work-Up?
Comparison of glass‐based and whole‐slide image‐based grade assignment for clear‐cell and papillary renal cell carcinoma: a multi‐cohort, international reproducibility study
Blocking the angiopoietin-2–dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasis
Enhancing Prostate Cancer Diagnosis: Artificial intelligence-Driven Virtual Biopsy for Optimal Magnetic Resonance Imaging-Targeted Biopsy Approach and Gleason Grading Strategy
Solitary fibrous tumor of the prostate with accompanying low-grade prostate cancer
An international multi-institutional validation study of the algorithm for prostate cancer detection and Gleason grading
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
<scp>BCG</scp> invokes superior <scp>STING</scp>‐mediated innate immune response over radiotherapy in a carcinogen murine model of urothelial cancer
EZH2-Targeted Therapies in Cancer: Hype or a Reality
Clinical Significance of Hotspot Mutation Analysis of Urinary Cell-Free DNA in Urothelial Bladder Cancer
Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression
Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities
Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladder
Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma
Performance of novel non-invasive urine assay UroSEEK in cohorts of equivocal urine cytology
Tumor immune microenvironment in non–muscle-invasive urothelial carcinoma of the bladder
Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer
NKX3.1 and Prostein Expression in Testicular Tissue and Sex Cord-stromal Tumors
Characterization of glycine‐<i>N</i>‐acyltransferase like 1 (GLYATL1) in prostate cancer
Focused Submission of Tissue for Radical Prostatectomy Following Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion-Targeted Biopsy
Active Surveillance of Small Renal Masses
Insulin-like growth factor-1 receptor expression in upper tract urothelial carcinoma
Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder
Toward personalized management in bladder cancer: the promise of novel molecular taxonomy